CTS

Electronic components manufacturer CTS Corporation (NYSE:CTS) reported revenue ahead of Wall Street’s expectations in Q3 2026, with sales up 4.6% year on year to $149.6 million.

CTS’s third quarter was marked by robust growth in diversified end markets and execution on margin expansion initiatives, resulting in a positive market reaction.

CTS Corporation reported stronger third quarter 2026 earnings, with basic EPS from continuing operations of US$0.62 and diluted EPS of US$0.61, and raised full year sales guidance to a range of US$580 million to US$590 million.

Here is how CTS (CTS) and Lattice Semiconductor (LSCC) have performed compared to their sector so far this year.

CTS (CTS) sparked fresh investor interest after third quarter 2026 earnings, with basic EPS from continuing operations at US$0.62, up from US$0.47 a year earlier, and full year sales guidance raised.

Shares of electronic components manufacturer CTS Corporation (NYSE:CTS) jumped 4.3% in the afternoon session after the company reported third-quarter 2026 financial results, with wider margins and higher cash flow, and raised its full-year sales and adjusted…

Shares of electronic components manufacturer CTS Corporation (NYSE:CTS) jumped 4.5% in the morning session after the company reported third-quarter 2026 financial results that topped analyst estimates and raised its full-year revenue and earnings outlook.

CTS (NYSE:CTS) reported third-quarter sales growth and record profitability, supported by higher revenue in its diversified end markets, favorable product mix and operational execution.

Moby summary of CTS Corporation's Q3 2026 earnings call

Medical segment surged 21% as company raised full-year guidance.